Asian Regional CRO Reports Record Setting Study Startup Times for Clinical Trials; An Ongoing Response to Pandemic or a New Industry Benchmark?

Asian scientist in the laboratory working at lab with test tube

One of Asia-Pacific’s largest regional contract research organizations (CRO) called Novotech, reports that many countries are fast-tracking their COVID-19 clients’ clinical trials with expedited review processes for treatment and vaccine candidates. In fact, Novotech reports another COVID-19 trial was just approved in under 9 days in South Korea—these study launch times are shattering the record books. The South Korean Ministry of Food and Drug Safety (MFDS) announced “Go-expedite”, a program expediting COVID-19 clinical trial review timelines.

Studies launched in record time across Asia

According to a recent press release published in EurekAlert!, the following countries are experiencing rapid acceleration of COVID-19 clinical trial reviews:

·       India: review/approval in 10 working days

·       Thailand: review/approval in 15 working days

·       Malaysia: review/approval in 20 working days


Dr. Yooni Kim, the Executive Director for Asia Operations of Novotech, reports that the regional rapid response represents an ...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee